American International Group, Inc. Landos Biopharma, Inc. Transaction History

American International Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.6 - $1.5 $1,394 - $3,486	-2,324 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.44 - $5.22 $234 - $850	-163 Reduced 6.55%	2,324 $3,000
Q4 2021 Feb 11, 2022	SELL	$4.7 - $15.0 $357 - $1,140	-76 Reduced 2.97%	2,487 $12,000
Q3 2021 Nov 12, 2021	SELL	$9.77 - $15.77 $10,336 - $16,684	-1,058 Reduced 29.22%	2,563 $37,000
Q2 2021 Aug 13, 2021	SELL	$9.26 - $12.53 $518 - $701	-56 Reduced 1.52%	3,621 $42,000
Q1 2021 May 07, 2021	BUY	$9.47 - $16.26 $34,821 - $59,788	3,677 New	3,677 $35,000

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.